Xuesong Dong

1.3k citations
41 papers · 1.1k indexed · h-index 18

Xuesong Dong

39 papers receiving 1.0k citations

Peers

Xuesong Dong
Comparison fields: 5 of 107
  • Orthopedics and Sports Medicine 196
  • Cancer Research 295
  • Hepatology 109
  • Oncology 215
  • Molecular Biology 404
Replace David Pfander with:
David Pfander Germany
Kazuhiro Maeda Japan
Olli Tynninen Finland
Yubo Sun United States
Jixing Ye China
Baoan Ma China
Ivan N. Vial United States
Jinteng Li China
Chunxi Ge United States
Xuesong Dong relative to David Pfander Germany David Pfander's profile →
Citations per field
00.5×2.5×
David Pfander · 1×
Citations per year

Countries citing papers authored by Xuesong Dong

Since Specialization
Citations

This map shows the geographic impact of Xuesong Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuesong Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuesong Dong more than expected).

Fields of papers citing papers by Xuesong Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuesong Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuesong Dong. The network helps show where Xuesong Dong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xuesong Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xuesong Dong Line = papers co-authored together Xuesong Dong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202112
2
Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44
20202
3 20180
4 20184
5 201713
6 201520
7 201526
8 201485
9 201439
10 2014126
11 201257
12 201218
13 201154
14 201112
15 201017
16 200952
17 200910
18 200725
19 200417
20
Debonding strength of cement lines in human cortical bone
19991

About Xuesong Dong

Xuesong Dong is a scholar working on Orthopedics and Sports Medicine, Hepatology and Oral Surgery, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (13 papers), Orthopaedic implants and arthroplasty (8 papers), Elasticity and Material Modeling (7 papers), Paraquat toxicity studies and treatments (6 papers), Angiogenesis and VEGF in Cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Dental Implant Techniques and Outcomes (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (196 citations), Cancer Research (295 citations) and Hepatology (109 citations). Xuesong Dong has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Xueying Sun, Xiaodu Wang, Haiquan Qiao, Hongchi Jiang, Xian Jiang, Yener N. Yeni, David P. Fyhrie, Huaqiang Zhu, Brian K. Bay and Roger Zauel. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Orthopaedics and Related Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026